Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Partial regimen replacement with aripiprazole to reduce serum prolactin in long-standing schizophrenia
jRCT1091220245Completed
- Sponsor
- Keiko Naono
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of aripiprazole in schizophrenia (2 arms), sponsored by Keiko Naono. Primary endpoint: Serum prolactin. Started Mar 2016; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT1091220245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220245.